Martin Soubrier
Soubrier, Martin, 1958-....
Soubrier, Martin
VIAF ID: 193843166 (Personal)
Permalink: http://viaf.org/viaf/193843166
Preferred Forms
- 100 0 _ ‡a Martin Soubrier
- 200 _ | ‡a Soubrier ‡b Martin
- 100 1 _ ‡a Soubrier, Martin, ‡d 1958- ..
- 100 1 _ ‡a Soubrier, Martin, ‡d 1958-....
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Absence d'amélioration de la prise en charge du risque cardiovasculaire dans la polyarthrite rhumatoïde débutante : résultats de la cohorte ESPOIR | |
Actualités et nouvelles perspectives dans les rhumatismes inflammatoires chroniques SFR 2010, 28 novembre-1er décembre 2010 | |
The effects of TNF-alpha inhibitor therapy on arterial stiffness and endothelial dysfunction in rheumatoid arthritis: a meta-analysis | |
Epstein-Barr virus infection associated hepatic lymphoma in a patient treated with methotrexate for rheumatoid arthritis | |
Une étude cas-témoin sur l'épaisseur intima-média et la rigidité artérielle dans la spondylarthrite ankylosante | |
Une étude ouverte sur l'efficacité du Pamidronate intra veineux dans la discopathie dégénérative érosive | |
Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study | |
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial | |
Evénements cardiovasculaires sous tocilizumab vs autres biothérapies : revue systématique avec méta-analyse en réseau | |
Evolution de l'efficience de l'enquête bactériologique des spondylodiscites infectieuses au cours des vingt dernières années | |
Exacerbation of interstitial lung disease during etanercept therapy: Two cases | |
Facteurs prédictifs de réponse aux anti-TNF chez les patients souffrant d' une polyarthrite rhumatoïde ou d' une spondyloarthropathie : cohorte RCVRIC | |
French law: what about a reasoned reimbursement of serum vitamin D assays? | |
French survey on the crossed needs on sexual health for chronic inflammatory rheumatism patients and healthcare professionals | |
Frequency of concomitant fibromyalgia in rheumatic diseases: Monocentric study of 691 patients | |
GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate | |
How to assess early rheumatoid arthritis in daily clinical practice | |
Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins | |
Impact du secukinumab sur la fonction endothéliale, la rigidité artérielle, le métabolisme glycémique et lipidique, comparativement à un traitement anti-TNF dans la spondyloarthrite axiale et le rhumatisme psoriasique | |
Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the 'ORA' registry | |
Insufficiency fracture. A survey of 60 cases and review of the literature | |
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus | |
Intravenous Immunoglobulins Improve Survival in Monoclonal Gammopathy-Associated Systemic Capillary-Leak Syndrome. | |
Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study | |
Late-onset spondyloarthropathy mimicking reflex sympathetic dystrophy syndrome | |
The learning curve of nurses for the assessment of swollen and tender joints in rheumatoid arthritis | |
Management of dyslipidaemia in high-risk patients with recent-onset rheumatoid arthritis: targets still not met despite specific recommendations. Results from the ESPOIR cohort during the first five years of follow-up | |
Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis | |
Neutrophilic dermatosis of the dorsal hands during thalidomide treatment | |
No change in the efficacy of infectious spondylodiscitis bacteriological testing over 20 years period | |
Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial | |
Oligo-arthritis and type IV hyperlipoproteinemia | |
Overview of biologic treatments in the elderly | |
Patient-perceived flares in rheumatoid arthritis: A sub-analysis of the STRASS treatment tapering strategy trial | |
Polymyalgia rheumatica: diagnosis and treatment | |
Polymyositis and pemphigus vulgaris in a patient: successful treatment with rituximab | |
Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, skin changes (POEMS) syndrome refractory to complete serum vascular endothelial growth factor (VEGF) blockade: insights from sequential VEGF monitoring | |
Predictive value of the usual clinical signs and laboratory tests in the diagnosis of septic arthritis | |
Prevalence and risk factors of low bone mineral density in spondyloarthritis and prevalence of vertebral fractures | |
Prévalence de la carence en vitamine D dans la polyarthrite rhumatoïde (PR) et association avec l'activité de la maladie : données de l'étude COMEDRA | |
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). | |
The Prevalence of Renal Impairment in Patients with Spondyloarthritis: Results from the International ASAS-COMOSPA Study. | |
Primary infectious spondylodiscitis in 51 patients over 75 years old: A comparative study | |
Psoriatic arthritis treated by anti-TNFs: a monocentric trial of 102 cases in Auvergne, France. | |
Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNFα chez les personnes souffrant de polyarthrite rhumatoïde | |
Recommendations of the French Society for Rheumatology. TNFα antagonist therapy in rheumatoid arthritis | |
Refractory hypocalcemia | |
Refractory rheumatic disorder: atypical postpregnancy osteoporosis | |
The relationship between weight status and metabolic syndrome in patients with rheumatoid arthritis and spondyloarthritis | |
Response to 'Statins accelerate the onset of collagen type II-induced arthritis in mice'. | |
Retention rates of adalimumab, etanercept, and infliximab as first- or second-line biotherapies for spondyloarthritis patients in daily practice in Auvergne (France). | |
Rheumatic and musculoskeletal features of Whipple disease: a report of 29 cases | |
Rheumatic disease presenting as septic arthritis: a report of 10 cases | |
Rheumatoid arthritis in the elderly in the era of tight control | |
Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE. | |
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry | |
Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients | |
Serious herpes zoster in rheumatoid arthritis under anti-interleukin-6 receptor antibody | |
Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis | |
Serum procalcitonin measurement is not a useful biomarker in the detection of primary infectious spondylodiscitis. | |
Spondyloarthropathies: an independent cardiovascular risk factor? | |
Streptococcal septic arthritis in adults. A study of 55 cases with a literature review | |
Le Syndrome POEMS | |
Synovites rhumatismales : l'activité doppler varie-t-elle dans la journée? : résultats préliminaires | |
The systemic capillary leak syndrome: a case series of 28 patients from a European registry | |
Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 Cases. | |
Timing of publication of abstracts of randomized controlled trials presented in congresses: The example of the European League against Rheumatism meeting | |
TNF alpha antagonist therapy and safety monitoring | |
TNFα antagonist therapy does not increase the Epstein-Barr virus burden in patients with rheumatoid arthritis or ankylosing spondylitis | |
Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients | |
Tolérance et efficacité du rituximab chez les sujets âgés traités pour une polyarthrite rhumatoïde : les données du registre AIR | |
Treatment of inflammatory muscle disease in adults | |
Utility of PET/CT in the diagnosis of inflammatory rheumatic diseases: a systematic review and meta-analysis | |
Variations in the metabolome in response to disease activity of rheumatoid arthritis | |
Vascular effects of nonsteroidal antiinflammatory drugs | |
Vascular endothelial growth factor levels and rheumatic diseases of the elderly | |
Viewpoints of dentists on the use of bisphosphonates in rheumatology patients | |
[Weakening osteopathies, chronic kidney disease, malabsorption, biological anomalies of calium/phosphorus metabolism: appropriate indications for a reasoned reimbursment of serum vitamin D measurement] |